Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raveendran K Pillai

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Indian Journal of Medical Research|June 3, 2017
Rare cancers: Challenges & issuesRaveendran K Pillai, K Jayasree
ACS Applied Bio Materials|January 12, 2022
Galactoxyloglucan Endowed Biogenic Nanoimmunobiotics Arrests Microbial Growth and Elicits Antitumor ImmunityManu M Joseph, Neethu Hari, Raveendran K Pillai, et al.
Translational Oncology|January 16, 2021
Corrigendum to ``Co-encapsulation of doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors'' [Translational Oncology 7 (2014), 525-536]Manu M Joseph, S R Aravind, Suraj K George, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 16, 2021
Corrigendum to "Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis" [Eur. J. Pharm. Biopharm. 93 (2015) 183-195]Manu M Joseph, S R Aravind, Suraj K George, et al.
Translational Oncology|November 13, 2014
Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumorsManu M Joseph, S R Aravind, Suraj K George, et al.
ACS Applied Materials & Interfaces|May 24, 2017
Exploration of Biogenic Nano-chemobiotics Fabricated by Silver Nanoparticle and Galactoxyloglucan with an Efficient Biodistribution in Solid Tumor Investigated by SERS FingerprintingManu M Joseph, Jyothi B Nair, Ramya N Adukkadan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 16, 2020
Targeted Theranostic Nano Vehicle Endorsed with Self-Destruction and Immunostimulatory Features to Circumvent Drug Resistance and Wipe-Out Tumor Reinitiating Cancer Stem CellsManu M Joseph, Adukkadan N Ramya, Vineeth M Vijayan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Indian Journal of Medical Research|June 3, 2017
Rare cancers: Challenges & issuesRaveendran K Pillai, K Jayasree
ACS Applied Bio Materials|January 12, 2022
Galactoxyloglucan Endowed Biogenic Nanoimmunobiotics Arrests Microbial Growth and Elicits Antitumor ImmunityManu M Joseph, Neethu Hari, Raveendran K Pillai, et al.
Translational Oncology|January 16, 2021
Corrigendum to ``Co-encapsulation of doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors'' [Translational Oncology 7 (2014), 525-536]Manu M Joseph, S R Aravind, Suraj K George, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 16, 2021
Corrigendum to "Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis" [Eur. J. Pharm. Biopharm. 93 (2015) 183-195]Manu M Joseph, S R Aravind, Suraj K George, et al.
Translational Oncology|November 13, 2014
Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumorsManu M Joseph, S R Aravind, Suraj K George, et al.
ACS Applied Materials & Interfaces|May 24, 2017
Exploration of Biogenic Nano-chemobiotics Fabricated by Silver Nanoparticle and Galactoxyloglucan with an Efficient Biodistribution in Solid Tumor Investigated by SERS FingerprintingManu M Joseph, Jyothi B Nair, Ramya N Adukkadan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 16, 2020
Targeted Theranostic Nano Vehicle Endorsed with Self-Destruction and Immunostimulatory Features to Circumvent Drug Resistance and Wipe-Out Tumor Reinitiating Cancer Stem CellsManu M Joseph, Adukkadan N Ramya, Vineeth M Vijayan, et al.
Pageof 1